Recently, researchers induced drug resistance through cisplatin exposure and found that reactive oxygen species (ROS)-mediated increase in PGC-1a might be one of the possible mechanisms of cisplatin resistance in NSCLC. The gene discussed is PPARGC1A; the disease is non-small cell lung carcinoma.